Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Codal Synto Ltd, 33 Theklas Lysioti Street, 3030 Limassol, Cyprus
Syntolexin 250 mg capsules.
Syntolexin 500 mg capsules.
| Pharmaceutical Form |
|---|
|
Capsule. Black-green hard gelatine capsules. |
Syntolexin 250mg: Each capsule contains cefalexin monohydrate equivalent to cefalexin base 250 mg.
Syntolexin 500 mg: Each capsule contains cefalexin monohydrate equivalent to cefalexin base 500 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cefalexin |
Cefalexin is an antibacterial agent of the cephalosporin class. Like other cephalosporins cefalexin exerts antibacterial activity by binding to and inhibiting the action of penicillin-binding proteins involved in the synthesis of bacterial cell walls. This leads to bacterial cell lysis and cell death. |
| List of Excipients |
|---|
|
Syntolexin capsules: magnesium stearate, gelatine, titanium dioxide (E171), iron oxide black (E172), iron oxide yellow (E172) and indigo carmine (E132). |
Syntolexin Capsules: PVC-Aluminium blisters in cartons of 16, 30 and 100 capsules and in plastic containers of 500 and 1000 capsules with a patient information leaflet.
Not all pack sizes may be marketed.
Codal Synto Ltd, 33 Theklas Lysioti Street, 3030 Limassol, Cyprus
Syntolexin 250 mg: 19827
Syntolexin 500 mg: 19828
Syntolexin 250 mg: 29/12/2005 / 16/11/2020
Syntolexin 500 mg: 29/12/2005 /16/11/2020
| Drug | Countries | |
|---|---|---|
| SYNTOLEXIN | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
